| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of GAP43 mRNA" | 26377693 |
| C036535 | 1,6-bis(cyclohexyloximinocarbonyl)hexane | "1,6-bis(cyclohexyloximinocarbonyl)hexane inhibits the reaction [FGF2 protein results in increased phosphorylation of GAP43 protein]" | 9852580 |
| C036535 | 1,6-bis(cyclohexyloximinocarbonyl)hexane | "1,6-bis(cyclohexyloximinocarbonyl)hexane inhibits the reaction [NCAM1 protein results in increased phosphorylation of GAP43 protein]" | 9852580 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "[2,2',4,4'-tetrabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of GAP43 mRNA" | 21436126 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "[2,2',4,4'-tetrabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of GAP43 protein" | 21436126 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GAP43 mRNA" | 21436126 |
| C511295 | 2,2',4,4'-tetrabromodiphenyl ether | "2,2',4,4'-tetrabromodiphenyl ether results in increased expression of GAP43 protein" | 21436126 |
| C049584 | 2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine | "2-amino-1-methyl-6-phenylimidazo(4,5-b)pyridine results in decreased expression of GAP43 mRNA" | 15059925 |
| C025946 | 3-methyladenine | 3-methyladenine inhibits the reaction [sodium arsenite results in decreased expression of GAP43] | 25639566 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C560597 | 6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide | "6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide inhibits the reaction [Scopolamine Hydrobromide results in decreased expression of GAP43 protein]" | 22096544 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] | 18375950 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of GAP43 mRNA | 15749267|2895956 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of GAP43 mRNA | 16483693 |
| D003913 | Dextroamphetamine | Dextroamphetamine results in decreased expression of GAP43 mRNA | 11377751 |
| D003913 | Dextroamphetamine | Dextroamphetamine results in increased expression of GAP43 mRNA | 11377751 |
| D016718 | Arachidonic Acid | Arachidonic Acid results in increased phosphorylation of GAP43 protein | 9852580 |
| D001151 | Arsenic | Arsenic results in decreased expression of GAP43 mRNA | 19654921 |
| D001151 | Arsenic | Arsenic results in decreased expression of GAP43 mRNA | 23600209 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of GAP43 mRNA | 26705709 |
| C030693 | Ashwagandha | Ashwagandha inhibits the reaction [Scopolamine Hydrobromide results in decreased expression of GAP43 protein] | 22096544 |
| D001280 | Atrazine | Atrazine results in increased expression of GAP43 mRNA | 22378314 |
| C072763 | azamethiphos | azamethiphos promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] | 28385489 |
| C547126 | AZM551248 | AZM551248 results in increased expression of GAP43 mRNA | 22323515 |
| C487081 | belinostat | belinostat results in increased expression of GAP43 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased expression of GAP43 mRNA | 26377693 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of GAP43 mRNA | 27195522 |
| D004958 | Estradiol | [Progesterone co-treated with Estradiol] results in decreased expression of GAP43 mRNA | 17404688 |
| C088060 | bisindolylmaleimide | bisindolylmaleimide inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] | 18375950 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of GAP43 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of GAP43 gene | 28505145 |
| D001786 | Blood Glucose | [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of GAP43 protein | 27693381 |
| D001905 | Botulinum Toxins | Botulinum Toxins results in increased expression of GAP43 protein | 8089707 |
| C013418 | bromfenacoum | bromfenacoum results in increased expression of GAP43 protein | 28903499 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of GAP43 mRNA | 20147733 |
| D020001 | 1-Butanol | 1-Butanol inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | 18004999 |
| D002104 | Cadmium | Cadmium results in decreased expression of GAP43 mRNA | 24376830 |
| D002220 | Carbamazepine | Carbamazepine affects the expression of GAP43 mRNA | 22634333 |
| C010063 | carbonyl sulfide | carbonyl sulfide results in decreased expression of GAP43 mRNA | 19395590 |
| C043211 | carvedilol | carvedilol results in decreased expression of GAP43 mRNA | 20359859 |
| C043211 | carvedilol | carvedilol results in decreased expression of GAP43 protein | 20359859 |
| C024714 | caryophyllene | caryophyllene results in increased expression of GAP43 protein | 27871898 |
| D004390 | Chlorpyrifos | Chlorpyrifos results in increased expression of GAP43 mRNA | 27018022 |
| D004390 | Chlorpyrifos | Chlorpyrifos affects the expression of GAP43 mRNA | 17452286 |
| D004390 | Chlorpyrifos | Chlorpyrifos promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] | 28385489 |
| D003010 | Clorgyline | Clorgyline results in decreased expression of GAP43 protein | 12480131 |
| C018021 | cobaltous chloride | Acetylcysteine inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] | 18375950 |
| C018021 | cobaltous chloride | bisindolylmaleimide inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] | 18375950 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of GAP43 mRNA | 18375950 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased phosphorylation of GAP43 protein | 18375950 |
| C018021 | cobaltous chloride | PRKCE protein promotes the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] | 18375950 |
| C018021 | cobaltous chloride | Zinc inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] | 18375950 |
| D003042 | Cocaine | Cocaine results in decreased expression of GAP43 mRNA | 12629581 |
| D016578 | Crack Cocaine | Crack Cocaine results in increased expression of GAP43 mRNA | 12629581 |
| D003520 | Cyclophosphamide | Cyclophosphamide results in increased expression of GAP43 protein | 10536274|9486479 |
| C037304 | cyhalothrin | cyhalothrin promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] | 28385489 |
| D003561 | Cytarabine | Cytarabine results in increased expression of GAP43 mRNA | 21198554 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether affects the expression of GAP43 protein | 18061678 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of GAP43 protein | 25194327 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of GAP43 protein | 18753049 |
| D016190 | Carboplatin | Carboplatin results in increased expression of GAP43 protein | 19435600 |
| D003976 | Diazinon | Diazinon results in increased expression of GAP43 mRNA | 17452286 |
| D004026 | Dieldrin | Dieldrin promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] | 28385489 |
| D002117 | Calcitriol | Calcitriol results in increased expression of GAP43 mRNA | 16002434 |
| D004237 | Diuron | Diuron results in decreased expression of GAP43 mRNA | 25152437 |
| D016291 | Dizocilpine Maleate | Dizocilpine Maleate inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] | 8774942 |
| D007980 | Levodopa | Levodopa results in increased expression of GAP43 protein | 25044243 |
| C508214 | (E)-N1-((6-chloro-3-pyridyl)methyl)-N2-cyano-N1-methylacetamidine | (E)-N1-((6-chloro-3-pyridyl)methyl)-N2-cyano-N1-methylacetamidine promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] | 28385489 |
| C118739 | entinostat | entinostat results in increased expression of GAP43 mRNA | 26272509 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| D000431 | Ethanol | Ethanol results in decreased expression of GAP43 mRNA | 15940294 |
| D000431 | Ethanol | Thyroxine inhibits the reaction [Ethanol results in decreased expression of GAP43 mRNA] | 15940294 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of GAP43 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAP43 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in decreased expression of GAP43 mRNA | 15834898|1735126 |
| D015025 | Zearalenone | Zearalenone results in decreased expression of GAP43 mRNA | 17557909 |
| D005411 | Flame Retardants | Flame Retardants results in increased expression of GAP43 protein | 16451863|1855017 |
| D005473 | Fluoxetine | Fluoxetine results in decreased expression of GAP43 mRNA | 17950272 |
| C061365 | flusilazole | flusilazole affects the expression of GAP43 mRNA | 22634333 |
| D005690 | Galactose | Galactose results in decreased expression of GAP43 mRNA | 16707173 |
| D005690 | Galactose | Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA] | 16707173 |
| C081021 | Go 6976 | Go 6976 inhibits the reaction [isophthalate analog results in increased expression of GAP43 protein] | 23643828 |
| D006533 | Heptachlor | Heptachlor promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] | 28385489 |
| D007099 | Imipramine | Imipramine results in decreased expression of GAP43 mRNA | 17950272 |
| C059768 | isophthalate | Go 6976 inhibits the reaction [isophthalate analog results in increased expression of GAP43 protein] | 23643828 |
| C059768 | isophthalate | isophthalate analog results in increased expression of GAP43 mRNA | 23643828 |
| C059768 | isophthalate | isophthalate analog results in increased expression of GAP43 protein | 23643828 |
| C098607 | JP8 aviation fuel | JP8 aviation fuel results in increased expression of GAP43 protein | 17337753 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of GAP43 mRNA | 26752646 |
| D007608 | Kainic Acid | Dizocilpine Maleate inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] | 8774942 |
| D007608 | Kainic Acid | Kainic Acid results in increased expression of GAP43 mRNA | 8774942 |
| D007608 | Kainic Acid | Pentobarbital inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] | 8774942 |
| C063302 | KN 62 | KN 62 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | 18004999 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in decreased expression of GAP43 mRNA | 12057914 |
| D008148 | Lovastatin | Lovastatin results in increased expression of GAP43 protein | 20694854 |
| D008148 | Lovastatin | Lovastatin results in increased expression of GAP43 protein | 20694854 |
| D008468 | Meclizine | Meclizine affects the expression of GAP43 protein | 12388792 |
| D008535 | Megestrol | Megestrol affects the expression of GAP43 protein | 12388792 |
| D008550 | Melatonin | Melatonin inhibits the reaction [Methamphetamine results in decreased expression of GAP43 protein] | 19409439 |
| D008555 | Melitten | Melitten results in increased phosphorylation of GAP43 protein | 9852580 |
| D008694 | Methamphetamine | Melatonin inhibits the reaction [Methamphetamine results in decreased expression of GAP43 protein] | 19409439 |
| D008694 | Methamphetamine | Methamphetamine results in decreased expression of GAP43 protein | 19409439 |
| D008704 | Methazolamide | Methazolamide affects the expression of GAP43 protein | 12388792 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 mRNA" | 23933227 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 protein" | 23933227 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 mRNA]" | 23933227 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "[Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 protein]" | 23933227 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 mRNA]" | 23933227 |
| D015632 | 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 protein]" | 23933227 |
| C005238 | mipafox | mipafox results in decreased expression of GAP43 protein | 27939611 |
| C523799 | MRK 003 | MRK 003 results in decreased expression of GAP43 mRNA | 21169257 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of GAP43 mRNA" | 25554681 |
| D009532 | Nickel | Nickel affects the expression of GAP43 mRNA | 18812211 |
| D009538 | Nicotine | "[Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 mRNA]" | 23933227 |
| D009538 | Nicotine | "[Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 protein]" | 23933227 |
| D009538 | Nicotine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 mRNA]" | 23933227 |
| D009538 | Nicotine | "Nicotine inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 protein]" | 23933227 |
| C009618 | O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate | "O,O-diethyl O-3,5,6-trichloro-2-pyridyl phosphate results in decreased expression of GAP43 protein" | 21704052 |
| D010070 | Oxalates | Oxalates inhibits the reaction [NGF protein results in increased expression of GAP43 protein] | 21981408 |
| C030110 | oxaliplatin | oxaliplatin inhibits the reaction [NGF protein results in increased expression of GAP43 protein] | 21981408 |
| D016877 | Oxidants | Oxidants results in increased expression of GAP43 mRNA | 18375950 |
| D010100 | Oxygen | [Blood Glucose deficiency co-treated with Oxygen deficiency] results in increased expression of GAP43 protein | 27693381 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of GAP43 mRNA | 26272509 |
| D010261 | Paraoxon | Paraoxon results in decreased expression of GAP43 protein | 27939611 |
| D010269 | Paraquat | Paraquat results in increased expression of GAP43 mRNA | 18198484 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of GAP43 mRNA | 22866812 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of GAP43 mRNA | 26705709 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of GAP43 protein | 16451863|1855017 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in decreased expression of GAP43 mRNA | 19954255 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of GAP43 mRNA | 19954255 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in increased expression of GAP43 protein modified form | 19954255 |
| D010424 | Pentobarbital | Pentobarbital inhibits the reaction [Kainic Acid results in increased expression of GAP43 mRNA] | 8774942 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of GAP43 protein | 19211617 |
| C076994 | perfluorooctane sulfonic acid | "[2,2',4,4'-tetrabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of GAP43 mRNA" | 21436126 |
| C076994 | perfluorooctane sulfonic acid | "[2,2',4,4'-tetrabromodiphenyl ether co-treated with perfluorooctane sulfonic acid] results in increased expression of GAP43 protein" | 21436126 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in decreased expression of GAP43 protein | 25524167 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of GAP43 mRNA | 21436126|2552416 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid results in increased expression of GAP43 protein | 21436126 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of GAP43 protein | 19211617 |
| D010622 | Phencyclidine | Phencyclidine results in increased expression of GAP43 mRNA | 11377751 |
| D010862 | Pilocarpine | Pilocarpine results in decreased expression of GAP43 protein | 15191797 |
| D010862 | Pilocarpine | Pilocarpine results in increased expression of GAP43 mRNA | 16134595 |
| C043435 | polylactic acid-polyglycolic acid copolymer | "[Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 mRNA]" | 23933227 |
| C043435 | polylactic acid-polyglycolic acid copolymer | "[Nicotine co-treated with polylactic acid-polyglycolic acid copolymer] inhibits the reaction [1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine results in decreased expression of GAP43 protein]" | 23933227 |
| D011189 | Potassium Chloride | 1-Butanol inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | 18004999 |
| D011189 | Potassium Chloride | CAMK2D protein affects the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | 18004999 |
| D011189 | Potassium Chloride | KN 62 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | 18004999 |
| D011189 | Potassium Chloride | PLD2 protein affects the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | 18004999 |
| D011189 | Potassium Chloride | Potassium Chloride results in increased expression of GAP43 mRNA | 18004999 |
| D011189 | Potassium Chloride | Potassium Chloride results in increased expression of GAP43 protein | 18004999 |
| D011189 | Potassium Chloride | U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | 18004999 |
| D011189 | Potassium Chloride | U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 protein] | 18004999 |
| D011374 | Progesterone | [Progesterone co-treated with Estradiol] results in decreased expression of GAP43 mRNA | 17404688 |
| D011374 | Progesterone | Progesterone inhibits the reaction [VPS54 mutant form results in increased expression of GAP43 mRNA] | 19693665 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of GAP43 mRNA | 24780913 |
| C030984 | pyrene | pyrene results in decreased expression of GAP43 mRNA | 22487263 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Galactose results in decreased expression of GAP43 mRNA] | 16707173 |
| C059514 | resveratrol | resveratrol results in decreased expression of GAP43 mRNA | 12002526 |
| C010327 | salinomycin | salinomycin results in decreased expression of GAP43 mRNA | 19682730 |
| D012524 | Sarin | Sarin results in decreased expression of GAP43 mRNA | 19522546 |
| D012601 | Scopolamine Hydrobromide | "6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide inhibits the reaction [Scopolamine Hydrobromide results in decreased expression of GAP43 protein]" | 22096544 |
| D012601 | Scopolamine Hydrobromide | Ashwagandha inhibits the reaction [Scopolamine Hydrobromide results in decreased expression of GAP43 protein] | 22096544 |
| D012601 | Scopolamine Hydrobromide | Scopolamine Hydrobromide results in decreased expression of GAP43 protein | 22096544 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of GAP43 mRNA | 12016162 |
| C017947 | sodium arsenite | 3-methyladenine inhibits the reaction [sodium arsenite results in decreased expression of GAP43] | 25639566 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of GAP43 | 25639566 |
| C049985 | staurosporine aglycone | staurosporine aglycone inhibits the reaction [NGF protein results in increased expression of GAP43 protein] | 27871898 |
| D013467 | Sulindac | Sulindac affects the expression of GAP43 protein | 12388792 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of GAP43 mRNA | 15708448 |
| D014284 | Triiodothyronine | Triiodothyronine results in increased expression of GAP43 protein | 15708448 |
| D043343 | Testosterone Propionate | Testosterone Propionate results in increased expression of GAP43 mRNA | 19427307 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of GAP43 mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of GAP43 mRNA | 17942748 |
| D019284 | Thapsigargin | Thapsigargin results in decreased expression of GAP43 mRNA | 22378314 |
| D013974 | Thyroxine | Thyroxine inhibits the reaction [Ethanol results in decreased expression of GAP43 mRNA] | 15940294 |
| D013974 | Thyroxine | Thyroxine results in increased expression of GAP43 mRNA | 15940294 |
| D013974 | Thyroxine | Thyroxine results in decreased expression of GAP43 mRNA | 17403546 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of GAP43 mRNA | 19464567 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of GAP43 mRNA | 20133372 |
| D014212 | Tretinoin | Tretinoin results in increased expression of GAP43 mRNA | 11027660|2193413 |
| D014212 | Tretinoin | Tretinoin results in increased expression of GAP43 protein | 16849523 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [NGF protein results in increased expression of GAP43 mRNA] | 28385489 |
| D014212 | Tretinoin | Tretinoin results in increased expression of GAP43 mRNA | 15708448 |
| D014212 | Tretinoin | Tretinoin results in increased expression of GAP43 protein | 15708448|1713047 |
| C009524 | tributyl phosphate | tributyl phosphate results in decreased expression of GAP43 mRNA | 27018022 |
| D014236 | Trichlorfon | Trichlorfon results in decreased expression of GAP43 protein | 27939611 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of GAP43 mRNA | 24935251|2627250 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of GAP43 mRNA | 15901671 |
| C005445 | triphenyl phosphate | triphenyl phosphate results in decreased expression of GAP43 mRNA | 27146889 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in increased expression of GAP43 mRNA" | 25461749|2582660 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of GAP43 mRNA" | 24717766 |
| C013320 | tris(2-butoxyethyl) phosphate | tris(2-butoxyethyl) phosphate results in decreased expression of GAP43 mRNA | 27018022 |
| C013320 | tris(2-butoxyethyl) phosphate | tris(2-butoxyethyl) phosphate results in decreased expression of GAP43 mRNA | 27146889 |
| C031324 | tris(chloroethyl)phosphate | tris(chloroethyl)phosphate results in increased expression of GAP43 mRNA | 27146889 |
| C031324 | tris(chloroethyl)phosphate | tris(chloroethyl)phosphate results in decreased expression of GAP43 mRNA | 24717766 |
| C031324 | tris(chloroethyl)phosphate | tris(chloroethyl)phosphate results in decreased expression of GAP43 protein | 24717766 |
| C046243 | tryptanthrine | tryptanthrine results in increased expression of GAP43 mRNA | 23500671 |
| D014415 | Tunicamycin | Tunicamycin results in decreased expression of GAP43 mRNA | 22378314 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 mRNA] | 18004999 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Potassium Chloride results in increased expression of GAP43 protein] | 18004999 |
| C022884 | undecane | undecane results in increased expression of GAP43 protein | 17337753 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of GAP43 mRNA | 25979313|2607246 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of GAP43 mRNA | 19101580|2317975 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of GAP43 mRNA | 26072468 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of GAP43 mRNA | 15901671 |
| D001335 | Vehicle Emissions | Vehicle Emissions affects the methylation of GAP43 gene | 25560391 |
| D014700 | Verapamil | Verapamil affects the expression of GAP43 protein | 12388792 |
| D024483 | Vitamin K 3 | Vitamin K 3 analog results in increased expression of GAP43 mRNA | 19273458 |
| C111237 | vorinostat | "[NOG protein co-treated with vorinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GAP43 mRNA" | 27188386 |
| C111237 | vorinostat | vorinostat results in increased expression of GAP43 mRNA | 26272509 |
| D015032 | Zinc | Zinc inhibits the reaction [cobaltous chloride results in increased phosphorylation of GAP43 protein] | 18375950 |